<<BACK -11- MORE>>

Critical Challenges and Landmark Advances in Venous Thromboembolism.
Program Chairman: Ajay Kakkar, MBBS, PhD, FRCS.  NEW    International Congress

Cancer, Clotting and Controversies— Critical Challenges and Landmark Advances in Venous Thrombosis. Program Chairman: Craig M. Kessler, MD.  NEW   National Congress

Evolving Approaches to Antithrombotic Therapy in Patients with Acute Ischemic Heart Disease-Establishing Evidence-and Collaboration-Based ACS Management Protocols for Interventional Cardiologists and Emergency Medicine Specialists: A National and Regional EDICT for ACS Initiative, New York; Program Chairmen, Gregg Stone, MD, FACC and Charles V. Pollack, MD, FACEP  NEW

Critical Challenges in Cardiovascular Medicine: Establishing Interventional Cardiology and Emergency Medicine Therapeutic Teams (EDICT) for ACS; Program Chairman: Steven V. Manoukian, MD, FACC  NEW

Optimizing Clinical Strategies in Heart Disease: Linking Science and Expert Analysis to Advances in Hypertension— Focus on Cardioselective Beta-Blockers and Risk Factor Management; Program Chairman: Michael Weber, MD

Advancing Management of Acute Coronary Syndromes—A National Experts’ Science-to-Strategy Summit and Satellite Symposium; Program Chairman: Peter B. Berger, MD, FACC  NEW | National Congress

Hot Cases in ACS: Managing Patients with High Risk Acute Coronary Syndromes—National Experts Weigh in on Strategies and the Evidence; Program Chairman, A. Michael Lincoff, MD; Panel Members: Elliott Antmann, MD, Peter Berger, MD, Magnus Ohman, MD  
NEW | National Congress

EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS: Critical Challenges in Cardiovascular Medicine—Establishing Seamless Interventional Cardiology and Emergency Medicine Clinical Strategies ; 2007, Boston, MA., Program Chairmen: Michael Gibson, MD and Charles Pollack, MD.

Advances in Hypertension, Heart Failure, and Global Risk Management in Heart Disease—The Current Role of Beta-Blockers; Program Chairman: Mark Dunlap, MD  NEW

Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, M

Advancing The Management of Acute Coronary Syndromes (ACS)—The Emergency Medicine Perspective; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM  National Congress

Optimizing Net Clinical Benefit in PCI: Applying Late-Breaking, Research in ACS Management to the Cardiac Catheterization Laboratory; Program Chairman: Jeffery J. Popma, MD, FSCAI   National Congress

ACS Management in the Emergency Department: Approaches to Dynamic Risk Assessment and Antithrombotic Therapy;
Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM   National Congress

Interventional Cardiology Update:  Redefining Efficacy for PCI and Management of Acute Coronary Syndromes—From Initial Presentation to the Cardiac Catheterization Laboratory; Program Chairman, Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP

Prevention and Management of Venous Thromboembolism —From Landmark Evidence to Optimal Clinical Practice; Program Chairman: Samuel Z. Goldhaber, MD

Critical Challenges in Orthopedic Surgery: A Science-to-Strategy CME Clinical Excellence Summit Focused on DVT Prophylaxis in High Risk Patients; Program Chairman, Javad Parvizi, MD, FRCS   National Congress

             <<BACK -11- MORE>>